Abstract
Molecular profiling of renal medullary carcinoma to reveal frequent alterations in chromatin remodeling genes and to identify EZH2 as a relevant therapeutic target.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have